Valeant Pharma (VRX) volatility at lower end of eight month range, Sequoia Fund exited position

Valeant Pharma (NYSE: VRX) is recently up 21c to $23.43 in the premarket on Sequoia Fund, the longtime and once the largest investor in Valeant exiting the investment last month. July call option implied volatility is at 82, August is at 86; compared to its 52-week range of 29 to

You May Also Be Interested In

• On Holding AG (ONON) call put ratio 4.5 calls to 1 put with a focus on September 28 and 29 calls
• Ginkgo Bioworks (DNA) 4K contracts of December 11 calls trade, share price up 13.3%
• Pegasystems (PEGA) call put ratio 1 call to 3.9 puts with a focus on 210 contracts of October 30 puts